Society guideline links: Bronchiolitis in infants and children

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●World Health Organization (WHO): Pocket book of hospital care for children – Guidelines for the management of common childhood illnesses, second edition (2013)

Canada

●Canadian Paediatric Society (CPS): Position statement on bronchiolitis – Recommendations for diagnosis, monitoring and management of children one to 24 months of age (2014, updated 2021)

●Choosing Wisely Canada: Don't prescribe antibiotics in adults with bronchitis/asthma and children with bronchiolitis (2021)

●CPS: Practice point on use of high-flow nasal cannula oxygen therapy in infants and children (2018)

United States

●Advisory Committee on Immunization Practices (ACIP): Recommendations on the use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children (2023)

●Centers for Disease Control and Prevention (CDC): Interim recommendations to protect infants from respiratory syncytial virus (RSV) during the 2023-2024 respiratory virus season – Limited availability of nirsevimab in the United States (2023)

●American Academy of Pediatrics (AAP): Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection (2014, reaffirmed 2019)

●National Perinatal Association (NPA): 2018 Respiratory syncytial virus (RSV) prevention clinical practice guideline – An evidence-based interdisciplinary collaboration (published 2017)

●AAP: Clinical practice guideline – The diagnosis, management, and prevention of bronchiolitis (2014)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on bronchiolitis in children – Diagnosis and management (2015, updated 2021)

●Choosing Wisely UK: Royal College of Paediatrics and Child Health – Bronchodilators should not be used in the treatment of mild or moderate presentations of acute bronchiolitis in children without any underlying conditions (2016)

●NICE: Quality standard on bronchiolitis in children (2016)

●Public Health England (PHE): The Green Book – Respiratory syncytial virus (2013, updated 2015)

India

●Indian Academy of Pediatrics (IAP): Standard treatment guidelines on bronchiolitis (2022)

Australia–New Zealand

●Paediatric Research in Emergency Departments International Collaborative (PREDICT): Australasian bronchiolitis guideline (2019)

●Choosing Wisely Australia: For children with bronchiolitis without other co-morbidities, do not delay discharge from an inpatient admission based on oxygen saturations alone if saturations are ≥90% (2018)

●New South Wales (NSW) Health: Clinical practice guideline for infants and children – Acute management of bronchiolitis (2018)

●South Australia (SA) Child Health Clinical Network: Clinical guideline for management of bronchiolitis in children (2013, revised 2018)

●Choosing Wisely Australia: Do not routinely undertake chest X-rays for the diagnosis of bronchiolitis in children or routinely prescribe salbutamol or systemic corticosteroids to treat bronchiolitis in children (2017)